Johnson & Johnson
JNJ
HK$1,233
Share price
0.28%
Change (1 day)
8.17%
Change (1 year)
Categories
Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
Johnson & Johnson (JNJ) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : HK$907.08 Billion
According to Johnson & Johnson's latest financial reports the company's total liabilities are HK$907.08 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Johnson & Johnson - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | HK$843.22 B | 9.3% |
| 2023-12-31 | HK$771.50 B | -10.7% |
| 2022-12-31 | HK$863.94 B | 2.59% |
| 2021-12-31 | HK$842.09 B | -2.68% |
| 2020-12-31 | HK$865.26 B | 13.07% |
| 2019-12-31 | HK$765.23 B | 4.85% |
| 2018-12-31 | HK$729.85 B | -3.84% |
| 2017-12-31 | HK$758.97 B | 38.26% |
| 2016-12-31 | HK$548.94 B | 13.76% |
| 2015-12-31 | HK$482.56 B | 2.65% |
| 2014-12-31 | HK$470.08 B | 3.4% |
| 2013-12-31 | HK$454.63 B | 3.77% |
| 2012-12-31 | HK$438.10 B | -0.28% |
| 2011-12-31 | HK$439.32 B | 21.85% |
| 2010-12-31 | HK$360.54 B | 5.45% |
| 2009-12-31 | HK$341.89 B | 4.35% |
| 2008-12-31 | HK$327.65 B | 11.66% |
| 2007-12-31 | HK$293.44 B | 20.78% |
| 2006-12-31 | HK$242.95 B | 55.48% |
| 2005-12-31 | HK$156.26 B | -6.49% |
| 2004-12-31 | HK$167.11 B | 0.77% |
| 2003-12-31 | HK$165.82 B | 19.07% |
| 2002-12-31 | HK$139.27 B | 25.3% |
| 2001-12-31 | HK$111.15 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | HK$921.43 B | 1.58% | 🇺🇸 USA |
 Merck MRK | HK$523.72 B | -42.26% | 🇺🇸 USA |
 Novartis NVS | HK$482.64 B | -46.79% | 🇨🇭 Switzerland |
 Sanofi SNY | HK$488.30 B | -46.17% | 🇫🇷 France |
 Stryker Corporation SYK | HK$196.82 B | -78.30% | 🇺🇸 USA |
 Medtronic MDT | HK$316.78 B | -65.08% | 🇮🇪 Ireland |
 Eli Lilly LLY | HK$577.25 B | -36.36% | 🇺🇸 USA |
 Abbott Laboratories ABT | HK$254.19 B | -71.98% | 🇺🇸 USA |
 GlaxoSmithKline GSK | HK$477.83 B | -47.32% | 🇬🇧 UK |
 Gilead Sciences GILD | HK$293.21 B | -67.67% | 🇺🇸 USA |